<DOC>
	<DOCNO>NCT02465632</DOCNO>
	<brief_summary>This randomize , double-blind , multiple-site , placebo-controlled , parallel-group study , design compare efficacy safety generic Clindamycin 1 % / Benzoyl peroxide 5 % topical gel ( Glenmark Generics , Ltd ) , market product BenzaClin® Topical Gel , Clindamycin 1 % / Benzoyl peroxide 5 % ( Valeant Pharmaceuticals , US ) treatment acne vulgaris .</brief_summary>
	<brief_title>To Study Generic Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gel ( Glenmark Generics , Ltd ) Treatment Acne Vulgaris .</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Male nonpregnant , nonlactating female , ≥12 ≤40 year age clinical diagnosis acne vulgaris . 2 . Have facial acne : ≥20 facial inflammatory lesion ( papule pustule ) ≥25 noninflammatory lesion ( open close comedo ) , ≤2 nodulocystic lesion ( nodule cyst ) IGA score 2 , 3 4 . 1 . Subject 2 facial nodular lesion ; nodule present document included inflammatory lesion count analysis . 2 . Subject active cystic acne . 3 . Subject acne conglobata . 4 . Subjects excessive facial hair beard , sideburn , moustache , etc . would interfere diagnosis assessment acne .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>